This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson’s disease and other synucleinopathies
npj Parkinson's Disease Open Access 22 July 2022
-
Spatiotemporal modulations in heterotypic condensates of prion and α-synuclein control phase transitions and amyloid conversion
Nature Communications Open Access 03 March 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Niu, M. et al. A longitudinal study on α-synuclein in plasma neuronal exosomes as a biomarker for Parkinson’s disease development and progression. Eur. J. Neurol. https://doi.org/10.1111/ene.14208 (2020)
Related article
Thompson, A. G. et al. Extracellular vesicles in neurodegenerative disease — pathogenesis to biomarkers. Nat. Rev. Neurol. 12, 346–357 (2016)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lemprière, S. Exosomal α-synuclein as a biomarker for Parkinson disease. Nat Rev Neurol 16, 242–243 (2020). https://doi.org/10.1038/s41582-020-0349-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41582-020-0349-z
This article is cited by
-
Spatiotemporal modulations in heterotypic condensates of prion and α-synuclein control phase transitions and amyloid conversion
Nature Communications (2022)
-
Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson’s disease and other synucleinopathies
npj Parkinson's Disease (2022)
-
Electromagnetic field-enhanced chiral dimanganese trioxide nanoparticles mitigate Parkinson’s disease
Science China Chemistry (2022)